USFDA pulls up Natco Pharma for manufacturing lapses

The US Food and Drug Administration said its investigators observed various violations at the pharmaceuticals plant located at Kothur.

BySouth First Desk

Published Apr 21, 2024 | 6:30 PMUpdatedApr 21, 2024 | 6:30 PM

Natco Pharma.

Natco Pharma failed to maintain cleanliness and sterilise equipment and utensils at appropriate intervals at its Telangana-based plant, as per the US’ health regulator USFDA. In a warning letter to the company, the USFDA said its investigators observed various violations at the finished pharmaceuticals plant located at Kothur Village in Telangana, which it inspected from 9 to 18 October, 2023.

Read the full story here